相关实验视频
Updated: Jun 19, 2026

12:54
Transient Expression of Proteins by Hydrodynamic Gene Delivery in Mice
Published on: May 5, 2014
脂蛋白L-I是人血清中的试体解因子
Luc Vanhamme1, Françoise Paturiaux-Hanocq, Philippe Poelvoorde
1Laboratory of Molecular Parasitology, IBMM, University of Brussels, 12, rue des Profs Jeener et Brachet, B6041 Gosselies, Belgium.
Nature
|March 7, 2003
概括
在Trypanosoma brucei rhodesiense中,血清耐药性相关蛋白 (SRA) 能够使寄生虫在人血清中存活. 这种阻力源于SRA.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 在东非,人类的睡眠病是由Trypanosoma brucei rhodesiense引起的.
- 寄生虫对正常人血清 (NHS) 溶解的抵抗是疾病病理学的关键因素.
- 血清耐药性相关蛋白 (SRA) 赋予了NHS的耐药性.
研究的目的:
- 阐明SRA赋予NHS抗性的机制.
- 为了确定NHS中负责试解的特定蛋白质.
- 了解SRA与人血清溶解因子之间的相互作用.
主要方法:
- 在寄生虫中定位SRA.
- 对SRA的N端α螺旋对NHS抗性功能的分析.
- 在SRA和人血清蛋白,特别是阿波利波蛋白L-I (apoL-I) 之间的相互作用研究.
- 耗尽NHS的apoL-I和评估解剂活性.
- 将apoL-I添加到耗尽的血清中以恢复溶解.
- 共聚焦显微镜来追踪apoL-I的吸收和定位.
主要成果:
- SRA是局部化的溶酶体蛋白质.
- SRA 的 N-终端α螺旋对NHS抗性至关重要.
- SRA的N端α螺旋直接与阿波利波蛋白L-I (apoL-I) 相互作用.
- 从NHS中耗尽apoL-I,取消了三分析活性.
- 添加apoL-I可以恢复敏感试酶的溶解.
- ApoL-I通过内细胞通路内化到 lysosome 中.
结论:
- 在正常人血清 (NHS) 中,Apolipoprotein L-I (apoL-I) 被确定为主要的试体溶解因子.
- 血清耐药性相关蛋白 (SRA) 通过其与 lysosome 内的 apoL-I 的相互作用,对NHS 介导的溶解产生耐药性.
- 这种相互作用机制为针对Trypanosoma brucei rhodesiense感染的治疗干预提供了潜在的目标.
相关概念视频
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

